Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical bevacizumab for dry eye disease vs conventional treatment
TCTR20171024002Phase 1Recruiting
- Sponsor
- Asia Research Center
- Start
- May 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1 trial of bevacizumab in dry eye syndrome (DED) (2 arms), sponsored by Asia Research Center. Started May 2017; status: recruiting.
02
Drugs
bevacizumab
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on TCTR20171024002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20171024002.